Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

April Jorge

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
The Lancet. Rheumatology|February 1, 2021
Hydroxychloroquine in the prevention of COVID-19 mortalityApril Jorge
Arthritis & Rheumatology (Hoboken, N.J.)|January 29, 2026
Optimizing Hydroxychloroquine in Lupus Treatment: Looking Beyond the 5 mg/kg Weight-Based Dosing CutoffApril Jorge
Scientific Reports|September 30, 2022
Comparing two machine learning approaches in predicting lupus hospitalization using longitudinal dataYijun Zhao, Dylan Smith, April Jorge
Mayo Clinic Proceedings|May 27, 2026
Systemic Lupus Erythematosus: What Every Clinician Needs to KnowAlí Duarte-García, Ali Ardekani, Shaun W Jackson, et al.
Rheumatology (Oxford, England)|June 24, 2026
Cardiometabolic protective mechanisms and efficacy of Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i) in SLEYoungmin Kim, April Jorge, Brittany N Weber, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 25, 2025
Glucagon-Like Peptide-1 Receptor Agonist Use and the Risk of Adverse Cardiac and Kidney Outcomes Among Patients With Systemic Lupus Erythematosus and Lupus NephritisApril Jorge, Aakash V Patel, Baijun Zhou, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 17, 2025
ReplyJacquelyn Nestor, Lingxiao Zhang, Hyon Choi, et al.
Annals of Internal Medicine|January 22, 2019
Renal Transplantation and Survival Among Patients With Lupus Nephritis: A Cohort StudyApril Jorge, Zachary S Wallace, Na Lu, et al.
Nature Reviews. Rheumatology|November 8, 2018
Hydroxychloroquine retinopathy - implications of research advances for rheumatology careApril Jorge, Cindy Ung, Lucy H Young, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 1, 2023
Comparative Risks of Infection With Belimumab Versus Oral Immunosuppressants in Patients With Nonrenal Systemic Lupus ErythematosusEmma Materne, Hyon Choi, Baijun Zhou, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
The Lancet. Rheumatology|February 1, 2021
Hydroxychloroquine in the prevention of COVID-19 mortalityApril Jorge
Arthritis & Rheumatology (Hoboken, N.J.)|January 29, 2026
Optimizing Hydroxychloroquine in Lupus Treatment: Looking Beyond the 5 mg/kg Weight-Based Dosing CutoffApril Jorge
Scientific Reports|September 30, 2022
Comparing two machine learning approaches in predicting lupus hospitalization using longitudinal dataYijun Zhao, Dylan Smith, April Jorge
Mayo Clinic Proceedings|May 27, 2026
Systemic Lupus Erythematosus: What Every Clinician Needs to KnowAlí Duarte-García, Ali Ardekani, Shaun W Jackson, et al.
Rheumatology (Oxford, England)|June 24, 2026
Cardiometabolic protective mechanisms and efficacy of Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i) in SLEYoungmin Kim, April Jorge, Brittany N Weber, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 25, 2025
Glucagon-Like Peptide-1 Receptor Agonist Use and the Risk of Adverse Cardiac and Kidney Outcomes Among Patients With Systemic Lupus Erythematosus and Lupus NephritisApril Jorge, Aakash V Patel, Baijun Zhou, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 17, 2025
ReplyJacquelyn Nestor, Lingxiao Zhang, Hyon Choi, et al.
Annals of Internal Medicine|January 22, 2019
Renal Transplantation and Survival Among Patients With Lupus Nephritis: A Cohort StudyApril Jorge, Zachary S Wallace, Na Lu, et al.
Nature Reviews. Rheumatology|November 8, 2018
Hydroxychloroquine retinopathy - implications of research advances for rheumatology careApril Jorge, Cindy Ung, Lucy H Young, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 1, 2023
Comparative Risks of Infection With Belimumab Versus Oral Immunosuppressants in Patients With Nonrenal Systemic Lupus ErythematosusEmma Materne, Hyon Choi, Baijun Zhou, et al.
Pageof 4